Manufacturing and Production
Bayer’s earnings beat estimates as blockbusters shine
April 26, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Eylea, Q1, Xarelto, blockbusters, growth, results, sales
Allergan breaks ground on $200 million expansion at Texas site
April 26, 2016 Manufacturing and Production Allergan, doubling, expansion, eye care, facility, investment, manufacturing, size, texas, waco
Novartis exploring almost $14-billion stake sale in Roche – reports
April 26, 2016 Manufacturing and Production, Sales and Marketing Financial, Merger & Acquisition, Novartis, Roche, Stake sale
EU grants approval for Gilead’s HIV treatment Descovy
April 26, 2016 Manufacturing and Production, Research and Development EU, HIV, approval, descovy, taf
Valeant names Joseph Papa as new chief executive officer
April 25, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Chairman, Valeant, joseph papa, new, new ceo, papa, pearson
PCI Pharma Services’ Ian Parsonage to Share Serialization Expertise at Global Track & Trace Conference
April 21, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ian parsonage, pci pharma, serialisation
Bayer says its Xarelto shows lower risk of stroke, brain haemorrhage for irregular heart rhythm condition vs BMS’ Coumadin
April 19, 2016 Manufacturing and Production, Research and Development Bayer, Bristol-Myers Squibb, anti blood-clot, drug trial
Bristol-Myers Squibb’s Opdivo shows positive results in early stage trials for advanced skin cancer
April 19, 2016 Manufacturing and Production, Research and Development Bristol-Myers Squibb, drug trial, immuno-therapy, oncology, opdivo
Roche reports 5% rise in Q1 sales boosted by cancer drugs
April 19, 2016 Manufacturing and Production, Sales and Marketing Q1, Roche, earnings, oncology drugs, results
GlaxoSmithKline opens new £56 million facility in Hertfordshire
April 19, 2016 Manufacturing and Production Andrew Witty, GSK, GlaxoSmithKline, Sir Andrew Witty, ellipta, facility, george freeman, inhalers, manufacturing, new, respiratory, ware
Eli Lilly drops development of diabetes drug in Phase III
April 19, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Eli Lilly, Transition Therapeutics, diabetes, drug trial
MSD receives fourth Breakthrough Therapy Designation for Keytruda
April 19, 2016 Manufacturing and Production, Research and Development Breakthrough Therapy Designation, FDA, Hodgkin lymphoma, MSD, Merck, breakthrough designation, breakthrough therapy, keytruda
Sanofi invests €300 million in new Belgian biologics site
April 19, 2016 Manufacturing and Production Belgium, Sanofi, belgian, flanders, geel, investment, manufacturing, pipeline
British Biosimilars Association launches in UK
April 18, 2016 Manufacturing and Production, Research and Development, Sales and Marketing ABPI, Napp, bba, bgma, british biosimilars association
Weekly Movers: Valeant, Depomed, Intercept Pharma, Insys Therapeutics and more…
April 18, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Depomed, Intercept Pharma, Relypsa, Share price, Stock Movement, Valeant, stock market
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
